Literature DB >> 22027334

The feasibility and safety of fiberoptic bronchoscopy during noninvasive ventilation in patients with established acute lung injury: another small brick in the wall.

Massimo Antonelli1.   

Abstract

In hypoxemic patients needing fiberoptic bronchoscopy (FOB), noninvasive ventilation (NIV) has been used to prevent gas-exchange deterioration associated with FOB and to compensate for the increase in work of breathing occurring during FOB, thus avoiding endotracheal intubation and its related complications. The application of NIV to allow FOB has been found of particular interest in the diagnosis of pneumonia in patients spontaneously breathing and in those who started NIV to assist FOB. There is less information for patients who were already receiving NIV for acute respiratory failure and who were scheduled to undergo FOB. In the previous issue of Critical Care, the study by Baumann and colleagues adds new information to this specific issue, addressing the feasibility and safety of FOB during NIV in patients with established hypoxemic respiratory failure.

Entities:  

Mesh:

Year:  2011        PMID: 22027334      PMCID: PMC3334728          DOI: 10.1186/cc10342

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  14 in total

1.  Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial.

Authors:  M Antonelli; G Conti; M Bufi; M G Costa; A Lappa; M Rocco; A Gasparetto; G U Meduri
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

2.  Pulmonary function in normal subjects after bronchoalveolar lavage.

Authors:  C C Lin; J L Wu; W C Huang
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

3.  Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device.

Authors:  B Maitre; S Jaber; S M Maggiore; E Bergot; J C Richard; H Bakthiari; B Housset; G Boussignac; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

4.  Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask.

Authors:  L Brochard; D Isabey; J Piquet; P Amaro; J Mancebo; A A Messadi; C Brun-Buisson; A Rauss; F Lemaire; A Harf
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

5.  Noninvasive positive-pressure ventilation vs. conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy.

Authors:  Massimo Antonelli; Giorgio Conti; Monica Rocco; Andrea Arcangeli; Franco Cavaliere; Rodolfo Proietti; Gianfranco Umberto Meduri
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

6.  Cardiorespiratory effects of flexible fiberoptic bronchoscopy in critically ill patients.

Authors:  C E Lindholm; B Ollman; J V Snyder; E G Millen; A Grenvik
Journal:  Chest       Date:  1978-10       Impact factor: 9.410

7.  Alterations in pulmonary mechanics and gas exchange during routine fiberoptic bronchoscopy.

Authors:  Y Matsushima; R L Jones; E G King; G Moysa; J D Alton
Journal:  Chest       Date:  1984-08       Impact factor: 9.410

8.  Noninvasive positive-pressure ventilation via face mask during bronchoscopy with BAL in high-risk hypoxemic patients.

Authors:  M Antonelli; G Conti; L Riccioni; G U Meduri
Journal:  Chest       Date:  1996-09       Impact factor: 9.410

9.  Fiberoptic bronchoscopy during noninvasive positive pressure ventilation delivered by helmet.

Authors:  Massimo Antonelli; Mariano Alberto Pennisi; Giorgio Conti; Giuseppe Bello; Salvatore Maurizio Maggiore; Vincenzo Michetti; Franco Cavaliere; Rodolfo Proietti
Journal:  Intensive Care Med       Date:  2002-11-29       Impact factor: 17.440

10.  Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation--a feasibility study.

Authors:  Hans Jörg Baumann; Hans Klose; Marcel Simon; Tarik Ghadban; Stephan A Braune; Jan K Hennigs; Stefan Kluge
Journal:  Crit Care       Date:  2011-07-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.